Journal of Psychopharmacology

Article	Citations
Activation of the aryl hydrocarbon receptor by clozapine induces preadipocyte differentiation and contributes to endothelial dysfunction	161
The relation between naturalistic use of psychedelics and perception of emotional stimuli: An event-related potential study comparing non-users and experienced users of classic psychedelics	90
Nighttime safety of daridorexant: Evaluation of responsiveness to an external noise stimulus, postural stability, walking, and cognitive function	78
Glutamate levels across deep brain structures in patients with a psychotic disorder and its relation to cognitive functioning	71
Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being	67
An efficient and label-free LC-MS/MS method for assessing drug’s activity at dopamine and serotonin transporters using transporter-transfected HEK293T cells	63
Histamine 3 receptor inverse agonist Samelisant (SUVN-G3031): Pharmacological characterization of an investigational agent for the treatment of cognitive disorders	62
A letter to the editor, associated with the article entitled “Efficacy and tolerability of combination treatments for major depression: Antidepressants plus second-generation antipsychotics vs esketam	60
Neural correlates of episodic memory decline following electroconvulsive therapy: An exploratory functional magnetic resonance imaging study	53
Dopaminergic and noradrenergic modulation of stress-induced alterations in brain activation associated with goal-directed behaviour	53
Antipsychotics, the heartland of clinical psychopharmacology?	53
The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls	51
Efficacy and safety of supraphysiologic doses of levothyroxine for patients with bipolar depression in adults: A systematic review	49
The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies	45
Profile of a short-acting κ-antagonist, LY2795050, on self-grooming behaviors, forced swim test and locomotor activity: sex comparison in mice	45
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder	45
Long-read sequencing of CYP2D6 may improve psychotropic prescribing and treatment outcomes: A systematic review and meta-analysis	43
Revisiting monoamine oxidase inhibitors: A potential dual-action therapy for patients with prostate cancer and comorbid depression?	43
Translational psychopharmacology	42
The dosing procedure that “makes the poison”: Comparing the effects of single versus cumulative alcohol administration methods on emotion recognition	38
Associations between lifetime classic psychedelic use and markers of physical health	38
The history of clozapine in clinical practice: From its introduction to a guideline proposing personalized titrations	38
Mice lacking melatonin MT2 receptors exhibit attentional deficits, anxiety and enhanced social interaction	35
From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions	34
Altered cerebellar-cortical resting-state functional connectivity in cannabis users	33

Exploring the effects of erythropoietin treatment on cortical thickness and hippocampal volume in patients with mood disorders undergoing electroconvulsive therapy: A randomized, placebo-controlled tr	33
Just a gut feeling: Faecal microbiota transplant for treatment of depression – A mini-review	33
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)	32
Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review	32
Psychedelics: Old drugs, new trips	31
Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study	30
Adult rat ultrasonic vocalizations and reward: Effects of propranolol and repeated cocaine administration	30
Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial	30
Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative results from a	29
5-HT1B receptor agonist attenuates cocaine self-administration after protracted abstinence and relapse in rats	29
Amphetamine use disorder is associated with striatum hypoactivation during anticipation of loss and reward	28
Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies	28
Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins	28
Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study	28
Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis	27
Hydrocortisone as an adjunct to brief cognitive-behavioural therapy for specific fear: Endocrine and cognitive biomarkers as predictors of symptom improvement	27
Reduced attentional lapses in male rats following a combination treatment of low-dose D-serine and atomoxetine	27
Association of cannabis use with neurocognition in adolescents with bipolar disorder	27
Science, safety and education: Informing the psychedelic treatment of psychiatric disorders	27
Responses to clinical treatment of bipolar versus unipolar depressive episodes in women versus men	27
Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review	26
Body mass index, waist circumference, insulin, and leptin plasma levels differentiate between clozapine-responsive and clozapine-resistant schizophrenia	26
Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trials	26
Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study	25
Belief changes associated with psychedelic use	25
Relationship between depression, prefrontal creatine and grey matter volume	24
Individual differences in cocaine-induced conditioned place preference in male rats: Behavioral and transcriptomic evidence	24
Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat	23
Intranasal oxytocin may help maintain romantic bonds by decreasing jealousy evoked by either imagined or real partner infidelity	22
Episodic foresight is impaired following acute alcohol intoxication	21
Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness	20
Selective effects of serotonin on choices to gather more information	20
Benzodiazepines for PTSD: Poor data quality and misleading advice	20
Exploring psychedelic-assisted therapy in the treatment of functional seizures: A review of underlying mechanisms and associated brain networks	19
Cognitive impairment in schizophrenia is associated with prefrontal–striatal functional hypoconnectivity and striatal dopaminergic abnormalities	19
Associations of treatment with hypnotics with suicide and attempted suicide: A nationwide cohort study	19
We need to talk: The urgent conversation on chronic pain, mental health, prescribing patterns and the opioid crisis	19
Catechol-O-methyltransferase activity does not influence emotional processing in men	18
Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review	18
A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression	18
D2-like receptor activation by intranasal dopamine attenuates fear responses induced by electrical stimulation of the dorsal periaqueductal grey matter, but fails to reduce aversion to pit	18
Psychedelics and the ‘inner healer’: Myth or mechanism?	18
Hyodeoxycholic acid inhibits lipopolysaccharide-induced microglia inflammatory responses through regulating TGR5/AKT/NF-κB signaling pathway	18
Co-use of psychedelics with other substances: Findings from the global psychedelic survey	17
Mining and analysis of security alert signals of valbenazine based on the Food and Drug Administration Adverse Event Reporting System database	17
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up	17
Altered states of consciousness in Danish healthy volunteers and recreational users of psilocybin and the possible impact of setting and intention: Danish validation of the five-dimensional altered st	17
Clozapine-specific proliferative response of peripheral blood-derived mononuclear cells in Japanese patients with clozapine-induced agranulocytosis	17
Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial	17
Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)	17

Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression	16
Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study	16
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study	16
Off the RADAR; questions regarding the trial protocol of a randomised controlled trial of antipsychotic reduction and discontinuation	15
Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate	15
The chronic effects of a combination of herbal extracts (Euphytose®) on psychological mood state and response to a laboratory stressor: A randomised, placebo-controlled, double blind study	15
Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review	15
The pseudoscience of lithium and suicide: Reanalysis of a misleading meta-analysis	14
Challenges for switching central nervous system and psychiatric medication products: A review of the literature	14
Dose–response relationships of psilocybin-induced subjective experiences in humans	14
Signatures of exposure to childhood trauma in young adults in the structure and neurochemistry of the superior temporal gyrus	14
Time-dependent association between selective serotonin reuptake inhibitors and hospitalization due to hyponatremia	14
Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice	14
Which are the demographic and clinical characteristics of patients who respond to subcutaneous esketamine?	14
Aripiprazole for treating delirium: A systematic review—Is it a valid yet understudied treatment?	14
Driving performance and ocular activity following acute administration of 10 mg methylphenidate: A randomised, double-blind, placebo-controlled study	14
Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial	13
Effects of positive mGlu5 modulation on D2 signaling and nicotine-conditioned place preference: Mechanisms of epigenetic inheritance in a transgenerational model of drug abuse vulnerability	13
Cell-based serum anticholinergic activity assay and working memory in cognitively healthy older adults before and after scopolamine: An exploratory study	13
The potential for medicinal cannabis to help manage challenging behaviour in people with intellectual disability: A perspective review	13
‘Memory, hither come’: Psychopharmacology of memory and more	13
Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials	13
Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment	13
Effects of modafinil and caffeine on night-time vigilance of air force crewmembers: A randomized controlled trial	13
Associative memory in alcohol-related contexts: An fMRI study with young binge drinkers	13
Impaired face symmetry detection under alcohol, but no ‘beer goggles’ effect	12
Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies	12
Do antipsychotic drugs shrink the brain? Probably not	12
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension	12
Repurposing psychopharmacology: A two-way street?	12
The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder	12
Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review	12
Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool	12
An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine	12
Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca	12
Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats	12
Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adults	12
Effects of benzodiazepine and orexin receptor antagonist on cognitive function revealed by auditory event-related potentials	12
Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short-term, low-dose fluoxetine: Involvement of the dorsal raphe nucleus and the dorsal periaq	11
Temporal profile of intranasal oxytocin in the human autonomic nervous system at rest: An electrocardiography and pupillometry study	11
Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age	11
The association between N-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls	11
Second International Consensus Study of Antipsychotic Dosing (ICSAD-2)	11
Ketamine: Therapeutic potential versus recreational misuse	11
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches	11
Relationship between change in social evaluation learning and mood in early antidepressant treatment: A prospective cohort study in primary care	11
The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis	11
Effects of 31 recombinant CYP2C19 variants on clomipramine metabolism in vitro	11
Pharmacological characterization of the selective orexin-1 receptor antagonist JNJ-61393215 in healthy volunteers	11
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action	10
Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response	10
Common protein networks for various drug regimens of major depression are associated with complement and immunity	10
Cocaine-specific speed-accuracy trade-off during anti-saccade testing differentiates patients with cocaine use disorder who achieve initial abstinence during treatment	10
A reflection on paradigmatic tensions within the FDA advisory committee for MDMA-assisted therapy	10
Abuse potential assessment of the dual orexin receptor antagonist daridorexant in rats	10
Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression	10
Effects of gamma-aminobutyric acid on working memory and attention: A randomized, double-blinded, placebo-controlled, crossover trial	10
Commentary: A framework for assessment of adverse events in psychedelic research	9
The biologically active compound of Withania somnifera (L.) Dunal, docosanyl ferulate, is endowed with potent anxiolytic properties but devoid of typical benzodiazepine-like side effects	9
Equasy revisited	9
A framework for assessment of adverse events occurring in psychedelic-assisted therapies	9
The Journal of Psychopharmacology: La Plus ça change. . .	9
Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study	9
Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial	9
The effect of AUT00206, a Kv3 potassium channel modulator, on dopamine synthesis capacity and the reliability of [18F]-FDOPA imaging in schizophrenia	9
Associations between regular cannabis use and brain resting-state functional connectivity in adolescents and adults	9
The psychedelic effects of cannabis: A review of the literature	9
Adenosine receptor stimulation inhibits methamphetamine-associated cue seeking	9
Behavioral profile of adult zebrafish acutely exposed to a selective dopamine uptake inhibitor, GBR 12909	9
Association between quetiapine use and self-harm outcomes among people with recorded personality disorder in UK primary care: A self-controlled case series analysis	9
Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and Health	9
Pharmaco-fUS in cognitive impairment: Lessons from a preclinical model	9
Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze	9
Aberrant inhibitory processing in the somatosensory cortices of cannabis-users	9
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease	9
GABAergic modulation of performance in response inhibition and interference control tasks	8
Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice	8
Comment on ‘Characteristics of poisonings involving ketamine in the United States, 2019–2021’	8
The NK1 antagonist L-733,060 facilitates sequence learning	8
Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial	8

Neurostructural and neurocognitive correlates of APOE ε4 in youth bipolar disorder	8
Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania	8
The impact of cannabidiol placebo on responses to an acute stressor: A replication and proof of concept study	8
MDMA enhances positive affective responses to social feedback	8
Bench, bedside, and balance	8
Younger, drunk, and fast: Paradoxical rapid reaction time in hazardous drinkers	8
The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats	8
Alprazolam-related deaths in Scotland, 2004–2020	8
Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth	7
Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial	7
A unified model of ketamine’s dissociative and psychedelic properties	7
More new research on the psychopharmacology of old drugs	7
Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes	7
Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial	7
Efficacy and tolerability of pharmacological interventions on metabolic disturbance induced by atypical antipsychotics in adults: A systematic review and network meta-analysis	7
Habitual caffeine intake, genetics and cognitive performance	7
Causes, clinical characteristics, and outcomes of high lithium levels and intoxications: Retrospective analysis of patient records	7
Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature	7
Projection-specific dopamine neurons in the ventral tegmental area participated in morphine-induced hyperalgesia and anti-nociceptive tolerance in male mice	7
Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: A meta-analysis of randomized controlled trials	7
Psilocybin’s effects on cognition and creativity: A scoping review	7
Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis	7
The safety of repeated ketamine dosing in paediatrics: A systematic review	7
Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group	7
Pharmacological treatment for anorexia nervosa: Why are we so skeptical?	6
The psychopharmacology of mood disorders	6
Cannabinoids: From the brain to society	6
Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use	6
A transdiagnostic systematic review and meta-analysis of ketamine’s anxiolytic effects	6
Comparison of locomotor stimulant and drug discrimination effects of four synthetic cathinones to commonly abused psychostimulants	6
Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment	6
Impaired discrimination of a subanesthetic dose of ketamine in a maternal immune activation model of schizophrenia risk	6
Clinical effects of CYP2D6 phenoconversion in patients with psychosis	6
Role of nitric oxide signaling in the antidepressant mechanism of action of ketamine: A randomized controlled trial	6
Award winning abstracts presented at the 12th Annual International College of Mental Health Pharmacy (CMHP) Conference, Northampton, UK on 7th and 8th October 2022	6
Why should pharmacological trials in schizophrenia employ functional magnetic resonance imaging (fMRI)?	6
Serotonin release by parachloroamphetamine in rats with high and low sociability: High prefrontal release capacity in sociable females	6
The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms	6
Refractory delirium tremens treated with ketamine	6
Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes	6
Elevated C-reactive protein among symptomatic youth with bipolar disorder	6
Regular cannabis use modulates the impact of HIV on the neural dynamics serving cognitive control	6
Subchronic PCP effects on DNA methylation and protein expression of NMDA receptor subunit genes in the prefrontal cortex and hippocampus of female rats	6
A phase 1 randomized, placebo-controlled study to investigate potential interactions between ASP8062, a positive allosteric modulator of the GABAB receptor, and morphine in recreational opi	6
Hyperdopaminergia in rats is associated with reverse effort-cost dependent performance	6
Intoxication without anticipation: Disentangling pharmacological from expected effects of alcohol	6
Effects of hydrocortisone and yohimbine on selective attention to emotional cues	6
Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals	6
The histamine system and cognitive function: An in vivo H3 receptor PET imaging study in healthy volunteers and patients with schizophrenia	6
Voluntary nicotine consumption and reward in a subset of diversity outbred founder strains	6
The interaction between kynurenine pathway, suicidal ideation and augmentation therapy with minocycline in patients with treatment-resistant depression	6
Three paradoxes related to the mode of action of pramipexole: The path from D2/D3 dopamine receptor stimulation to modification of dopamine-modulated functions	5
Visualizing classification of drugs used in psychotic disorders: A ‘subway map’ representing mechanisms, established classes and informal categories	5
A phase 1 study to assess potential interaction between ASP8062 and alcohol in healthy adult subjects	5
Evidence for the atherogenic index of plasma as a potential biomarker for cardiovascular disease in schizophrenia	5
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review	5
Ketamine for refractory depression: Save the best for last?	5
The New Zealand drug harms ranking study: A multi-criteria decision analysis	5
Unveiling potential adverse events associated with escitalopram oxalate: A real-world analysis based FDA adverse event reporting system database	5
Not too quick on “Debunking the myth of ‘Blue Mondays’”	5
Clozapine and the aryl hydrocarbon receptor	5
Combining bioinformatics, network pharmacology and artificial intelligence to predict the target genes of S-ketamine for treating major depressive disorder	5
Haloperidol dopamine receptor occupancy and antagonism correspond to delirium agitation scores and EPS risk: A PBPK-PD modeling analysis	5
Oral sodium oxybate does not alter plasma kisspeptin levels in healthy male volunteers	5
Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats	5
Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study	5
Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression	5
Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression	5
Impact of childhood adversity on acute subjective effects of stimulant and opioid drugs: Evidence from placebo-controlled studies in healthy volunteers	5
Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review	5
Aspirin may be more suitable for patients with major depression: Evidence from two-sample Mendelian randomization analysis	4
Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics	4
Sub-anesthetic doses of ketamine increase single cell entrainment in the rat auditory cortex during auditory steady-state response	4
Toward effective oxytocin interventions in autism: Overcoming challenges and harnessing opportunities	4
Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice	4
Clinical quandaries in psychotic disorders: the road is long, with many a winding turn	4
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)	4
Acute treatment with 5-hydroxytryptophan increases social approach behaviour but does not activate serotonergic neurons in the dorsal raphe nucleus in juvenile male BALB/c mice: A model of human disor	4
Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer’s disease: Machine learning approaches	4
No evidence that post-training dopamine D2 receptor agonism affects fear generalization in male rats	4
Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis	4
The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility	4
Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems	4
Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights	4
The burden associated with, and management of, difficult-to-treat depression in patients under specialist psychiatric care in the United Kingdom	4
Efficacy of onabotulinumtoxinA in the treatment of unipolar major depression: Systematic review, meta-analysis and meta-regression analyses of double-blind randomised controlled trials	4
Pharmacological characterization of a novel putative nootropic beta-alanine derivative, MB-005, in adult zebrafish	4
Postpartum depression: A role for psychedelics?	4
The relationship between Parkinson’s disease and sexual hyperactivity secondary to drug treatment: A systematic review	4
QTc prolongation in patients with schizophrenia taking antipsychotics: Prevalence and risk factors	4
Effects of CYP2D6*4 polymorphism on the steady-state concentration of paroxetine in patients diagnosed with depressive episode and comorbid alcohol use disorder	4
Isoginkgetin treatment attenuated lipopolysaccharide-induced monoamine neurotransmitter deficiency and depression-like behaviors through downregulating p38/NF-κB signaling pathway and suppressing micr	4
Ketamine: A new chapter for clinical psychopharmacology?	4
β-carboline-independent antidepressant-like effect of the standardized extract of the barks of Mimosa tenuiflora (Willd) Poir. occurs via 5-HT2A/2C receptors in mice	4
Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised control	4